Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac for Suicidality in Depressed Patients
NCT01413854Phase 2Withdrawn
- Sponsor
- Region Skåne
- Start
- Aug 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diclofenac in major depressive disorder (MDD), Suicidality, sponsored by Region Skåne. Planned start Aug 2011; status: withdrawn.
02
Drugs
diclofenac
03
Conditions
major depressive disorder (MDD)Suicidality
Beyond the preview
Go deeper on NCT01413854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413854.